))
Dexmedetomidine: The Alpha-2 Enigma in Anesthesia and Beyond
Manage episode 486570666 series 3590090
Content provided by Jeremy Stanley. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jeremy Stanley or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Dexmedetomidine — or “Dex” — has become one of the most intriguing and versatile drugs in the anesthesia world. In this episode of Anesthesia Alchemy with hosts Lynn Macksey, MSN, CRNA and Garry Brydges, PhD, DNP, MBA, CRNA, ACNP-BC, FAAN dive deep into the pharmacology, clinical application, and emerging research surrounding this alpha-2 agonist.
Here’s some of what we discuss in this episode:
🧠 CNS receptor action and sedative pathways
💉 IV, buccal, spinal, and local delivery methods
🫁 Organ protection and anti-inflammatory effects
🛏️ Potential future use as a sleep aid
🧬 Promising research on cancer immunity and stress modulation
Visit us online: https://beyondthemaskpodcast.com/
The 1099 CRNA Institute: https://aana.com/1099
Get the CE Certificate here (and directly submit to the NBCRNA): https://beyondthemaskpodcast.com/wp-content/uploads/2020/04/Beyond-the-Mask-CE-Cert-FILLABLE.pdf
Help us grow by leaving a review: https://podcasts.apple.com/us/podcast/beyond-the-mask-innovation-opportunities-for-crnas/id1440309246
416 episodes
Share
